Literature DB >> 25759209

The risks of risk scores for stroke risk assessment in atrial fibrillation.

Peter Brønnum Nielsen1, Tze-Fan Chao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25759209     DOI： 10.1160/TH15-03-0210

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  13 in total

1.  Stroke prevention in atrial fibrillation: Where are we now?

Authors:  Gregory Y H Lip
Journal:  Indian Heart J       Date:  2015-11-28

2.  Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.

Authors:  Line Melgaard; Anders Gorst-Rasmussen; Lars Hvilsted Rasmussen; Gregory Y H Lip; Torben Bjerregaard Larsen
Journal:  PLoS One       Date:  2016-03-25       Impact factor: 3.240

3.  Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA2DS2-VASc Score of 1 (Men) or 2 (Women)?

Authors:  Yuan Hung; Tze-Fan Chao; Chia-Jen Liu; Ta-Chuan Tuan; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Jo-Nan Liao; Fa-Po Chung; Wen-Yu Lin; Wei-Shiang Lin; Shu-Meng Cheng; Tzeng-Ji Chen; Gregory Y H Lip; Shih-Ann Chen
Journal:  J Am Heart Assoc       Date:  2016-10-04       Impact factor: 5.501

Review 4.  Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention.

Authors:  Farhan Shahid; Eduard Shantsila; Gregory Y H Lip
Journal:  F1000Res       Date:  2016-12-20

5.  Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients.

Authors:  Tommy Andersson; Anders Magnuson; Ing-Liss Bryngelsson; Ole Frøbert; Karin M Henriksson; Nils Edvardsson; Dritan Poçi
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

Review 6.  Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.

Authors:  Tatjana S Potpara; Nikolaos Dagres; Nebojša Mujović; Dragan Vasić; Milika Ašanin; Milan Nedeljkovic; Francisco Marin; Laurent Fauchier; Carina Blomstrom-Lundqvist; Gregory Y H Lip
Journal:  Adv Ther       Date:  2016-12-08       Impact factor: 3.845

Review 7.  Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.

Authors:  Hans-Christoph Diener; James Aisenberg; Jack Ansell; Dan Atar; Günter Breithardt; John Eikelboom; Michael D Ezekowitz; Christopher B Granger; Jonathan L Halperin; Stefan H Hohnloser; Elaine M Hylek; Paulus Kirchhof; Deirdre A Lane; Freek W A Verheugt; Roland Veltkamp; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2017-03-21       Impact factor: 29.983

8.  Comparison of Different Dosages of Alteplase in Atrial Fibrillation-Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan.

Authors:  Sheng-Feng Lin; Chien-Fu Chen; Han-Hwa Hu; Bo-Lin Ho; Chih-Hung Chen; Lung Chan; Huey-Juan Lin; Yu Sun; Yung-Yang Lin; Po-Lin Chen; Shinn-Kuang Lin; Cheng-Yu Wei; Yu-Te Lin; Jiunn-Tay Lee; A-Ching Chao
Journal:  J Am Heart Assoc       Date:  2022-01-20       Impact factor: 6.106

9.  Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study.

Authors:  Peter Brønnum Nielsen; Torben Bjerregaard Larsen; Flemming Skjøth; Thure Filskov Overvad; Gregory Y H Lip
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

10.  Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study.

Authors:  Line Melgaard; Thure Filskov Overvad; Flemming Skjøth; Jeppe Hagstrup Christensen; Torben Bjerregaard Larsen; Gregory Y H Lip
Journal:  ESC Heart Fail       Date:  2018-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.